好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

IVIG Is Effective and Well Tolerated in the Treatment of Acute MS Exacerbation
MS and Related Diseases
(-)
069
Authors/Disclosures
Hanna-Maija Kuusisto, MD No disclosure on file
Sara Razmjou-Schwarz, MD (Mclaren Macomb hospital) No disclosure on file
No disclosure on file
Fen Bao Fen Bao has nothing to disclose.
No disclosure on file
Kalyan Yarraguntla, MD (University Health Center) Dr. Yarraguntla has nothing to disclose.
Irina Elovaara, MD, PhD No disclosure on file
Samuel Lichtman-Mikol, BA (Wayne State University) Mr. Lichtman-Mikol has nothing to disclose.
No disclosure on file
No disclosure on file
Christina Caon, RN, BS (38 North Street) Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
No disclosure on file
Christine Lebrun Frenay, MD, FAAN (CRCSEP Neurologie) Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Carla E. Santiago-Martinez (Wayne State University) Ms. Santiago-Martinez has nothing to disclose.
Navid Seraji-Bozorgzad, MD (University of Michigan Medicine-Neurology) No disclosure on file
Evanthia Bernitsas, MD, FAAN (Wayne State School of Medicine) Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Omar A. Khan, MD, PhD (Dept of Neuro/Wayne State Univ Sch of Med) No disclosure on file